OTCPK:GPHG

Stock Analysis Report

Global Pharm Holdings Group

Executive Summary

Global Pharm Holdings Group, Inc., through its subsidiaries, engages in the distribution of pharmaceuticals-related products, Chinese herb cultivation, and preparation of raw materials for medicine in China.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • Global Pharm Holdings Group's last earnings update was 2857 days ago.
  • Global Pharm Holdings Group is not covered by any analysts.

Share Price & News

How has Global Pharm Holdings Group's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:GPHG

0.6%

US Healthcare

1.1%

US Market


1 Year Return

n/a

OTCPK:GPHG

-7.7%

US Healthcare

2.1%

US Market

No trading data on GPHG.

No trading data on GPHG.


Share holder returns

GPHGIndustryMarket
7 Day0%0.6%1.1%
30 Day0%-0.9%3.7%
90 Dayn/a0.02%2.3%
1 Yearn/a-6.3%-7.7%4.4%2.1%
3 Yearn/a31.5%26.2%47.0%37.4%
5 Yearn/a65.6%55.8%61.6%43.8%

Price Volatility Vs. Market

How volatile is Global Pharm Holdings Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Global Pharm Holdings Group undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Global Pharm Holdings Group is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Global Pharm Holdings Group has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine Global Pharm Holdings Group's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Global Pharm Holdings Group regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Global Pharm Holdings Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Global Pharm Holdings Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Global Pharm Holdings Group performed over the past 5 years?

0.1%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Global Pharm Holdings Group has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Global Pharm Holdings Group's financial position?


In this section we usually analyse Global Pharm Holdings Group's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Global Pharm Holdings Group has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of GPHG’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Global Pharm Holdings Group's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Global Pharm Holdings Group's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Global Pharm Holdings Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Global Pharm Holdings Group's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Global Pharm Holdings Group has not reported any payouts.

Unable to verify if Global Pharm Holdings Group's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Global Pharm Holdings Group has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Global Pharm Holdings Group's salary, the management and board of directors tenure and is there insider trading?

9.1yrs

Average management tenure


CEO

Yunlu Yin (52yo)

9.1yrs

Tenure

US$30,000

Compensation

Mr. Yin Yunlu has been Chairman and Chief Executive Officer of Top Flight Game Birds, Inc. since August 6, 2010. Mr. Yunlu served as the Chief Executive Officer and President of BioPharm Asia Inc. from May ...


Management Age and Tenure

9.1yrs

Average Tenure

49yo

Average Age

The average tenure for the Global Pharm Holdings Group management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

8.6yrs

Average Tenure

60yo

Average Age

The tenure for the Global Pharm Holdings Group board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • Yunlu Yin (52yo)

    Chairman and Chief Executive Officer

    • Tenure: 9.1yrs
    • Compensation: US$30.00k
  • Dan Li (49yo)

    Vice President and Secretary

    • Tenure: 9.1yrs
    • Compensation: US$420.91k
  • Fu An (44yo)

    Chief Financial Officer and Director

    • Tenure: 8.6yrs
    • Compensation: US$569.55k
  • Yanliang Song

    Vice President In-Charge of Operations

    • Tenure: 8.7yrs

Board Members

  • Simon Wong (68yo)

    Non-Executive Director

    • Tenure: 7.7yrs
  • Gene Bennett (71yo)

    Director

    • Tenure: 8.6yrs
  • Yunlu Yin (52yo)

    Chairman and Chief Executive Officer

    • Tenure: 9.1yrs
    • Compensation: US$30.00k
  • Fu An (44yo)

    Chief Financial Officer and Director

    • Tenure: 8.6yrs
    • Compensation: US$569.55k

Company Information

Global Pharm Holdings Group, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Global Pharm Holdings Group, Inc.
  • Ticker: GPHG
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: US$559.245k
  • Shares outstanding: 37.28m
  • Website: https://www.globalpharmholdings.com

Location

  • Global Pharm Holdings Group, Inc.
  • Rongchao Tower
  • 29th Floor, Tower B
  • Shenzhen
  • Guangdong Province
  • 518026
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GPHGOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDAug 2010

Biography

Global Pharm Holdings Group, Inc., through its subsidiaries, engages in the distribution of pharmaceuticals-related products, Chinese herb cultivation, and preparation of raw materials for medicine in Chin ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/17 00:10
End of Day Share Price2019/08/13 00:00
Earnings2011/09/30
Annual Earnings2010/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.